Lanreotide Autogel in the Treatment of Idiopathic Refractory Diarrhea: Results of an Exploratory, Controlled, Before and After, Open-label, Multicenter, Prospective Clinical Trial
Somatostatin analogues have the ability to reduce gastrointestinal secretions and motility. Lanreotide Autogel decreased symptoms and improved quality of life in these patients.

Related Post